WASION HOLDINGS (03393) repurchased 400,000 shares for HK$5.1465 million on September 29.
WASION HOLDINGS (03393) announced that on September 29, 2026, the company repurchased 400,000 shares for HK$5.1465 million, at a repurchase price of HK$12.78 to HK$12.96 per share.
WASION HOLDINGS (03393) announced that on September 29, 2026, the company repurchased 400,000 shares for HK$5.1465 million, at a repurchase price of HK$12.78 to HK$12.96 per share.
Related Articles
CSPC PHARMA(01093): The Phase Ib clinical trial of JMT206 injection for weight management in overweight or obese adult patients has officially been initiated at the first research center in China.
EMPEROR CULTURE (00491) Announces Annual Results with Net Profit of HK$1.257 Million, Turning Around from a Loss Year-on-Year
CSPC PHARMA (01093): Recombinant Herpes Zoster Vaccine (SYS 6052) Receives Clinical Trial Approval in the United States
CSPC PHARMA(01093): The Phase Ib clinical trial of JMT206 injection for weight management in overweight or obese adult patients has officially been initiated at the first research center in China.
EMPEROR CULTURE (00491) Announces Annual Results with Net Profit of HK$1.257 Million, Turning Around from a Loss Year-on-Year
CSPC PHARMA (01093): Recombinant Herpes Zoster Vaccine (SYS 6052) Receives Clinical Trial Approval in the United States
